Soleno Therapeutics, Inc.
SLNONASDAQHealthcare
$53.01
+$0.00(+0.00%)
Market Cap$2.8B
P/E Ratio—
52W High$90.3199
52W Low$29.43
Soleno Therapeutics, Inc.（SLNO）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · SLNO · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.19B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.19B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | 98.58% | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.04B | $0.08B | $0.03B | $0.02B | $0.02B |
| G&A Expenses | $0.00B | $0.11B | $0.01B | $0.01B | $0.01B |
| Total Operating Expenses | $0.17B | $0.19B | $0.04B | $0.02B | $0.03B |
| Operating Income | $0.01B | ($0.19B) | ($0.04B) | ($0.02B) | ($0.03B) |
| Operating Margin %(computed) | 7.85% | — | — | — | — |
| Interest Income | $0.02B | $0.01B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.02B | ($0.18B) | ($0.04B) | ($0.02B) | ($0.03B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | $0.02B | ($0.18B) | ($0.04B) | ($0.02B) | ($0.03B) |
| Net Margin %(computed) | 10.97% | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.41 | $-4.38 | $-2.36 | $-2.87 | $-5.81 |
| Wtd Avg Shares | 0.05B | 0.04B | 0.02B | 0.01B | 0.01B |
| EBITDA | $0.03B | ($0.17B) | ($0.04B) | ($0.02B) | ($0.03B) |
| EBITDA Margin %(computed) | 14.91% | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Soleno Therapeutics, Inc.
关于Soleno Therapeutics, Inc.（SLNO）损益表
Soleno Therapeutics, Inc.（SLNO）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，SLNO实现营收$0.19B，毛利润$0.19B（毛利率98.58%），净利润$0.02B（净利率10.97%）。
常见问题
SLNO · 4 问Soleno Therapeutics, Inc.（SLNO）2025财年营收为$0.19B，同比up—%。
SLNO revenueSLNO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08